BRITISH AMERICAN TOBACCO PLC Re (BMT.DU)
| Previous close | 33.80 |
| Open | 33.98 |
| Bid | 33.61 x N/A |
| Ask | 33.84 x N/A |
| Day's range | 33.41 - 33.98 |
| 52-week range | 33.26 - 42.32 |
| Volume | |
| Avg. volume | 76 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Evening Standard
FTSE 100 Live: Unilever price warning, AstraZeneca and BAT post results
Blue-chip companies Unilever, AstraZeneca and British American Tobacco today lead a busy session for end-of-year corporate earnings. AstraZeneca boss Pascal Soriot reported a 25% rise in revenues to $44.3 billion (£36.6 billion) and said he expects to see another year of double-digit revenue growth in 2023. Unilever profits topped 8 billion euros (£7.1 billion) last year, partly thanks to higher prices for its consumer goods brands including Hellman’s, Domestos and Ben & Jerry’s. It warned that while inflation is tempering, there are most cost increases to come this year.
- Evening Standard
BAT vaping division set to turn a profit a year ahead of schedule
The division is now expected to be profitable by 2024, but shares declined in early trading
- Yahoo Finance UK
FTSE 100: BAT pins hopes on e-cigarette sales as it forecasts revenue growth
British American Tobacco (BAT) reported full-year sales growth of between 2% and 4% after an increase in consumer use of its e-cigarette range.
